España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Belite Bio
BLTE
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$49.93
-0.4
-0.79%
At Close: -
$46.17
-3.76
-7.53%
After Hours: Jul 9, 8:00 AM EDT
15 minutes delayed
Get Report
Comment
Belite Bio (BLTE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Belite Bio (NASDAQ:BLTE) Stock
Belite Bio Stock (NASDAQ: BLTE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on Be...
Benzinga Newsdesk
Thursday, June 13, 2024
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Wednesday, June 12, 2024
Belite Bio Announces That Its Lead Pipeline, ...
Benzinga Newsdesk
Thursday, May 16, 2024
Benchmark Reiterates Buy on Belite Bio, Maint...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Be...
Benzinga Newsdesk
Tuesday, May 14, 2024
Belite Bio Q1 2024 GAAP EPS $(0.27) Beats $(0...
Benzinga Newsdesk
Monday, May 06, 2024
Belite Bio Presents Additional Analysis From ...
Benzinga Newsdesk
Friday, April 26, 2024
Reported Earlier, Belite Bio Secures $25M In ...
Benzinga Newsdesk
Friday, March 22, 2024
HC Wainwright & Co. Maintains Buy on Belite B...
Benzinga Newsdesk
Belite Bio Announces PMDA Submission of Tinla...
Benzinga Newsdesk
Wednesday, March 13, 2024
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Tuesday, March 12, 2024
Belite Bio Q4 EPS $(0.25) Beats $(0.30) Estim...
Benzinga Newsdesk
Wednesday, December 27, 2023
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Thursday, December 14, 2023
Expert Ratings for Belite Bio
Benzinga Insights
Maxim Group Initiates Coverage On Belite Bio ...
Benzinga Newsdesk
Sunday, December 10, 2023
Belite Bio Received Approval To Initiate Tinlarebant Phase 3 Clinical Trial For GA in Switzerland
Charles Gross
Wednesday, November 15, 2023
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Tuesday, November 14, 2023
Earnings Scheduled For November 14, 2023
Benzinga Insights
Belite Bio Q3 EPS $(0.40) Down From $(0.10) Y...
Benzinga Newsdesk
Tuesday, November 07, 2023
Benchmark Reiterates Buy on Belite Bio, Maint...
Benzinga Newsdesk
Monday, November 06, 2023
HC Wainwright & Co. Maintains Buy on Belite B...
Benzinga Newsdesk
Belite Bio Presented Final Data From A 24-mon...
Benzinga Newsdesk
Tuesday, October 17, 2023
Belite Bio Announces NMPA Submission For Tinl...
Benzinga Newsdesk
Wednesday, August 30, 2023
Belite Bio shares are trading lower. Not seei...
Benzinga Newsdesk
Monday, August 14, 2023
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, August 10, 2023
Expert Ratings for Belite Bio
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Wednesday, August 09, 2023
Earnings Scheduled For August 9, 2023
Benzinga Insights
Belite Bio Q2 EPS $(0.26) Down From $(0.12) Y...
Benzinga Newsdesk
Friday, August 04, 2023
Belite Bio Receives Approval To Initiate Tinl...
Benzinga Newsdesk
Friday, July 28, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Benzinga Insights
Cantor Fitzgerald Initiates Coverage On Belit...
Benzinga Newsdesk
Thursday, July 27, 2023
Belite Bio Doses First Subject In Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant For Geographic Atrophy
Happy Mohamed
Wednesday, July 26, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
Benzinga Insights
SVB Leerink Initiates Coverage On Belite Bio ...
Benzinga Newsdesk
Tuesday, July 25, 2023
The Latest Analyst Ratings for Belite Bio
Benzinga Insights
Benchmark Reiterates Buy on Belite Bio, Maint...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Monday, July 24, 2023
Belite Bio Completes Enrollment In Its Pivota...
Benzinga Newsdesk
Tuesday, June 27, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, June 26, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
Lisa Levin
Tuesday, June 20, 2023
Analyst Expectations for Belite Bio's Future
Benzinga Insights
Benchmark Reiterates Buy on Belite Bio, Maint...
Benzinga Newsdesk
Friday, June 16, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Friday, June 09, 2023
Top 5 Health Care Stocks That Are Set To Fly In Q2
Lisa Levin
Monday, June 05, 2023
HC Wainwright & Co. Reiterates Buy on Belite ...
Benzinga Newsdesk
Wednesday, May 31, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch